Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Andrews

Showing results (721-730 of 754) with videos related to

Pageof 76
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 3, 2023
Mental Health of Royal Canadian Mounted Police at the Start of the Cadet Training ProgramR Nicholas Carleton, Laleh Jamshidi, Kirby Q Maguire, et al.
Journal of Medicinal Chemistry|August 20, 2015
Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3Justin K Murray, Yi-Xin Qian, Benxian Liu, et al.
Infection and Immunity|September 22, 2006
A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challengeS J Dunachie, M Walther, J E Epstein, et al.
Journal of Medicinal Chemistry|May 27, 2011
Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: discovery and structure-activity relationships of a series of quinoline and quinoxaline derivativesNobuko Nishimura, Aaron Siegmund, Longbin Liu, et al.
Journal of the American College of Cardiology|November 21, 2009
Genotype-phenotype aspects of type 2 long QT syndromeWataru Shimizu, Arthur J Moss, Arthur A M Wilde, et al.
Journal of Medicinal Chemistry|July 26, 2014
Discovery of clinical candidate 1-(4-(3-(4-(1H-benzo[d]imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)ethanone (AMG 579), a potent, selective, and efficacious inhibitor of phosphodiesterase 10A (PDE10A)Essa Hu, Ning Chen, Matthew P Bourbeau, et al.
Journal of Medicinal Chemistry|December 22, 2016
The Discovery and Hit-to-Lead Optimization of Tricyclic Sulfonamides as Potent and Efficacious Potentiators of Glycine ReceptorsHoward Bregman, Jeffrey R Simard, Kristin L Andrews, et al.
Haematologica|October 27, 2018
Chronic sympathetic driven hypertension promotes atherosclerosis by enhancing hematopoiesisAnnas Al-Sharea, Man K S Lee, Alexandra Whillas, et al.
ACS Medicinal Chemistry Letters|October 16, 2024
Rapid Affinity and Microsomal Stability Ranking of Crude Mixture Libraries of Histone Deacetylase InhibitorsSriram Tyagarajan, Christine L Andrews, Douglas C Beshore, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2014
Phosphoinositide-3-kinase inhibitors: evaluation of substituted alcohols as replacements for the piperazine sulfonamide portion of AMG 511Brian A Lanman, Anthony B Reed, Victor J Cee, et al.
Pageof 76

Showing results (721-730 of 754) with videos related to

Sort By:
Pageof 76
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 3, 2023
Mental Health of Royal Canadian Mounted Police at the Start of the Cadet Training ProgramR Nicholas Carleton, Laleh Jamshidi, Kirby Q Maguire, et al.
Journal of Medicinal Chemistry|August 20, 2015
Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3Justin K Murray, Yi-Xin Qian, Benxian Liu, et al.
Infection and Immunity|September 22, 2006
A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challengeS J Dunachie, M Walther, J E Epstein, et al.
Journal of Medicinal Chemistry|May 27, 2011
Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: discovery and structure-activity relationships of a series of quinoline and quinoxaline derivativesNobuko Nishimura, Aaron Siegmund, Longbin Liu, et al.
Journal of the American College of Cardiology|November 21, 2009
Genotype-phenotype aspects of type 2 long QT syndromeWataru Shimizu, Arthur J Moss, Arthur A M Wilde, et al.
Journal of Medicinal Chemistry|July 26, 2014
Discovery of clinical candidate 1-(4-(3-(4-(1H-benzo[d]imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)ethanone (AMG 579), a potent, selective, and efficacious inhibitor of phosphodiesterase 10A (PDE10A)Essa Hu, Ning Chen, Matthew P Bourbeau, et al.
Journal of Medicinal Chemistry|December 22, 2016
The Discovery and Hit-to-Lead Optimization of Tricyclic Sulfonamides as Potent and Efficacious Potentiators of Glycine ReceptorsHoward Bregman, Jeffrey R Simard, Kristin L Andrews, et al.
Haematologica|October 27, 2018
Chronic sympathetic driven hypertension promotes atherosclerosis by enhancing hematopoiesisAnnas Al-Sharea, Man K S Lee, Alexandra Whillas, et al.
ACS Medicinal Chemistry Letters|October 16, 2024
Rapid Affinity and Microsomal Stability Ranking of Crude Mixture Libraries of Histone Deacetylase InhibitorsSriram Tyagarajan, Christine L Andrews, Douglas C Beshore, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2014
Phosphoinositide-3-kinase inhibitors: evaluation of substituted alcohols as replacements for the piperazine sulfonamide portion of AMG 511Brian A Lanman, Anthony B Reed, Victor J Cee, et al.
Pageof 76